P855: Traceback testing for ovarian cancer: Implementer and participant perspectives*
Year: 2024
Type: article
Abstract: As part of a National Cancer Institute-funded cooperative agreement, the Feasibility and Assessment of a Cascade Traceback Screening program for ovarian cancer (FACTS) study, Kaiser Permanente Mid-Atlantic States (KPMAS), Geisinger Health System, and Kaiser Permanente Washington (KPW) designed and evaluated Traceback testing programs in the clinical environment. Programs include retrospectively identifying survivors of ovarian, fallopian tube, or peritoneal cancer who have not received genetic testing and outreaching to offer genetic testing.
Source: Genetics in Medicine Open
Authors: Nora Henrikson, Alanna Rahm, Paula Blasi, Tracey Leitzel, Pim Suwannarat, Adrienne Deneal, Kathleen Leppig, Aaron Scrol, Daniela Canedo, M. Cabell Jonas
Language: English
Subfield: Genetics
Domain: Life Sciences
Open Access status: gold
Estimated APC paid: $3,200
OpenAlex ID: W4392606702